Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CYR61/CCN1: A novel mediator of redox response in corneal stromal cells of keratoconus. | Exp Eye Res | 2024 | 39277098 | PubTator, text mining | PubMed |
| The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells. | Int J Mol Sci | 2024 | 39273316 | PubTator, text mining | PubMed |
| The Application of Regenerated Silk Fibroin in Tissue Repair. | Materials (Basel) | 2024 | 39203101 | PubTator, text mining | PubMed |
| Research advances on silence information regulator 6 as a potential therapeutic target for bone regeneration and repair. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2024 | 39183069 | PubTator, text mining | PubMed |
| Uncovering underlying physical principles and driving forces of cell differentiation and reprogramming from single-cell transcriptomics. | Proc Natl Acad Sci U S A | 2024 | 39150785 | PubTator, text mining | PubMed |
| IGF2BP1-Mediated Regulation of CCN1 Expression by Specific Binding to G-Quadruplex Structure in Its 3'UTR. | Biochemistry | 2024 | 39133064 | PubTator, text mining | PubMed |
| Hypoxia-initiated Cysteine-rich protein 61 secretion promotes chemoresistance of acute B lymphoblastic leukemia cells. | Am J Cancer Res | 2024 | 39113880 | PubTator, text mining | PubMed |
| Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction. | Matrix Biol | 2024 | 39098433 | PubTator, text mining | PubMed |
| Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells. | FASEB J | 2024 | 39082187 | PubTator, text mining | PubMed |
| A new insight into the pathway behind spontaneous recurrent pregnancy loss: decreased CYR61 gene expression. | Rev Assoc Med Bras (1992) | 2024 | 39045957 | PubTator, text mining | PubMed |
| Targeting the senescence-related genes MAPK12 and FOS to alleviate osteoarthritis. | J Orthop Translat | 2024 | 39007035 | PubTator, text mining | PubMed |
| Nanomechanics of CCN1-Mediated Staphylococcus aureus Phagocytosis. | Nano Lett | 2024 | 38959438 | PubTator, text mining | PubMed |
| Characterization of sciatic nerve myelin sheath during development in C57BL/6 mice. | Eur J Neurosci | 2024 | 38951719 | PubTator, text mining | PubMed |
| Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profiling. | PeerJ | 2024 | 38938617 | PubTator, text mining | PubMed |
| Prognostic Function and Immunologic Landscape of a Predictive Model Based on Five Senescence-Related Genes in IPF Bronchoalveolar Lavage Fluid. | Biomedicines | 2024 | 38927453 | PubTator, text mining | PubMed |
| Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion. | Discov Med | 2024 | 38926109 | PubTator, text mining | PubMed |
| Matricellular proteins in immunometabolism and tissue homeostasis. | BMB Rep | 2024 | 38919018 | PubTator, text mining | PubMed |
| CYR61 Acts as an Intracellular Microtubule-Associated Protein and Coordinates Mitotic Progression via PLK1-FBW7 Pathway. | Int J Biol Sci | 2024 | 38904029 | PubTator, text mining | PubMed |
| Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells. | Anticancer Drugs | 2024 | 38900643 | PubTator, text mining | PubMed |
| Human trophoblast invasion and migration are mediated by the YAP1-CCN1 pathway: defective signaling in trophoblasts during early-onset severe preeclampsia†. | Biol Reprod | 2024 | 38874283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=10